K-975 NEW
| Price | $35 | $80 | Get Latest Price |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: K-975 | CAS No.: 2563855-03-6 |
| Purity: 99.43% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | K-975 |
| Description | K-975 is a highly selective, orally active TEAD inhibitor, effectively inhibiting protein-protein interactions between TEAD and YAP1/TAZ. |
| In vitro | K-975 inhibits the cell proliferation of NRF2-non-expressing malignant pleural mesothelioma (MPM) cell lines, protein-protein interaction (PPI) between Halo-TAZ and TEAD1/4 and Halo-YAP and endogenous TEAD1/4 in NCl-H226 cells and the reporter activity in NCl-H661/CTGF-Luc cells with the maximum of ~70%, at concentration of 0.1-10000 nM at 144 h and 24 h, respectively [1]. K-975 decreases the expression of IGFBP3, CTGF and NPPB mRNAs, and increases the expression of FBXO32 mRNA in NCl-H226 cells [1]. |
| In vivo | K-975 (10-300 mg/kg; p.o. twice daily for 14 days) suppresses tumor growth by inhibiting TEAD-YAP1/TAZ signaling in MPM xenograft mouse models [1]. |
| Storage | Store at low temperature,Keep away from direct sunlight,Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 140 mg/mL (486.55 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (34.75 mM), Suspension. 10% DMSO+90% Saline : < 10 mg/mL (34.75 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | Yes-associated protein | YAP1 | YAP | TEAD,YAP1/TAZ | TEAD | TAZ | pleural | mesothelioma | malignant | K-975 | K975 | K 975 | Inhibitor | inhibit | Cys359 | cancer | antitumor |
| Inhibitors Related | AICAR | MY-1076 | TDI-011536 | YAP-TEAD-IN-3 | DC-TEADin02 | Verteporfin | MSC-4106 | Thiostrepton | OPN-9652 | VT107 | VT104 | MYF-01-37 |
| Related Compound Libraries | Highly Selective Inhibitor Library | Cysteine Covalent Library | Bioactive Compound Library | Inhibitor Library | Stem Cell Differentiation Compound Library | PPI Inhibitor Library | Orally Active Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | Wnt/Hedgehog/Notch Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | ||
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-06 | ||
|
VIP4Y
|
shandong perfect biotechnology co.ltd
|
2026-03-27 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY